Len Heller, longtime head of University of Kentucky's research commercialization efforts, including developing the Coldstream Research Campus, announced Thursday that he will retire March 1.
"I leave behind a highly capable team of professionals who will continue their important work on behalf of UK and the commonwealth," Heller said.
Heller was named vice president for commercialization and economic development in 2006. He was instrumental in the formation of the venture capital effort Bluegrass Angels. He had been CEO of WTT Inc., one of UK's first successful startup companies. WTT developed drug tests for racehorses; it was sold to Neogen in 1991 and has returned over $2.2 million to UK in royalties.